Office: 205 Pavilion
Phone: (412) 648-7219
Dr. Philip Empey is the Associate Director for Pharmacogenomics of the Pitt/UPMC Institute of Personalized Medicine and leads the PreCISE-Rx and Test2Learn teams to implement pharmacogenomics clinical, research, and educational initiatives. As a clinician-scientist in the Department of Pharmacy and Therapeutics, Dr. Empey conducts NIH-funded clinical and translational research aimed at understanding the mechanisms of the variability in drug response to improve medication-related outcomes in critically-ill patients.
He received his PharmD from the University of Rhode Island, completed PGY1 and PGY2 residencies in Pharmacy Practice and Critical Care at the University of Kentucky, and is a Board Certified Pharmacotherapy Specialist. He earned a PhD in Clinical Pharmaceutical Sciences at the University of Kentucky before completing postdoctoral research training at the University of Pittsburgh.
Current research interests include understanding the role/impact of xenobiotic transporters following neurological injury, transporter pharmacogenomics, pharmacogenomics clinical implementation, collection of medication-related phenotype information, and genotype-phenotype discovery. Dr. Empey teaches at the graduate level in pharmacokinetics, pharmacogenomics, and drug transporters in the Schools of Pharmacy, Medicine, and Nursing. He also has a research interest in innovative educational models to transform education.